Accelerate Diagnostics, Inc.
AXDX
$0.859
$0.08911.56%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 3.03M | 3.30M | 2.92M | 2.81M | 2.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.03M | 3.30M | 2.92M | 2.81M | 2.97M |
| Cost of Revenue | 2.39M | 3.19M | 2.12M | 1.80M | 2.13M |
| Gross Profit | 633.00K | 107.00K | 799.00K | 1.01M | 841.00K |
| SG&A Expenses | 5.79M | 7.76M | 7.56M | 10.11M | 8.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.76M | 17.95M | 15.51M | 18.87M | 16.93M |
| Operating Income | -10.73M | -14.65M | -12.59M | -16.06M | -13.96M |
| Income Before Tax | -12.43M | 1.04M | -32.58M | -16.80M | -14.69M |
| Income Tax Expenses | 564.00K | 131.00K | 156.00K | -- | -77.00K |
| Earnings from Continuing Operations | -13.00M | 910.00K | -32.74M | -16.80M | -14.61M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.00M | 910.00K | -32.74M | -16.80M | -14.61M |
| EBIT | -10.73M | -14.65M | -12.59M | -16.06M | -13.96M |
| EBITDA | -9.91M | -13.83M | -11.77M | -15.26M | -13.17M |
| EPS Basic | -0.89 | 0.06 | -2.97 | -1.71 | -1.50 |
| Normalized Basic EPS | -0.53 | -0.74 | -0.81 | -1.07 | -0.95 |
| EPS Diluted | -0.89 | 0.06 | -2.97 | -1.71 | -1.50 |
| Normalized Diluted EPS | -0.53 | -0.73 | -0.81 | -1.07 | -0.95 |
| Average Basic Shares Outstanding | 14.58M | 14.43M | 11.01M | 9.83M | 9.75M |
| Average Diluted Shares Outstanding | 14.58M | 14.55M | 11.01M | 9.83M | 9.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
